JP2023533855A5 - - Google Patents
Info
- Publication number
- JP2023533855A5 JP2023533855A5 JP2023502881A JP2023502881A JP2023533855A5 JP 2023533855 A5 JP2023533855 A5 JP 2023533855A5 JP 2023502881 A JP2023502881 A JP 2023502881A JP 2023502881 A JP2023502881 A JP 2023502881A JP 2023533855 A5 JP2023533855 A5 JP 2023533855A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- formula
- acceptable salt
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052574P | 2020-07-16 | 2020-07-16 | |
| US202063052561P | 2020-07-16 | 2020-07-16 | |
| US63/052,574 | 2020-07-16 | ||
| US63/052,561 | 2020-07-16 | ||
| PCT/US2021/034599 WO2022015423A1 (en) | 2020-07-16 | 2021-05-27 | ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533855A JP2023533855A (ja) | 2023-08-04 |
| JP2023533855A5 true JP2023533855A5 (https=) | 2025-09-12 |
Family
ID=79293345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502881A Pending JP2023533855A (ja) | 2020-07-16 | 2021-05-27 | イソキノリン化合物およびそのＡｈＲ不均衡の治療への使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US11267788B2 (https=) |
| EP (1) | EP4185566A4 (https=) |
| JP (1) | JP2023533855A (https=) |
| KR (1) | KR20230041021A (https=) |
| CN (1) | CN116157387A (https=) |
| AU (1) | AU2021308209A1 (https=) |
| CA (1) | CA3185793A1 (https=) |
| IL (1) | IL299756A (https=) |
| MX (1) | MX2023000263A (https=) |
| WO (1) | WO2022015423A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023533855A (ja) | 2020-07-16 | 2023-08-04 | ダーマヴァント サイエンシーズ ゲーエムベーハー | イソキノリン化合物およびそのＡｈＲ不均衡の治療への使用 |
| WO2024020170A1 (en) * | 2022-07-21 | 2024-01-25 | Allianthera (Suzhou) Biopharmaceutical Co., Ltd. | Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof |
| US20260069585A1 (en) * | 2022-08-30 | 2026-03-12 | Dermavant Sciences GmbH | ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES |
| WO2024152993A1 (zh) * | 2023-01-17 | 2024-07-25 | 上海泽德曼医药科技有限公司 | 稠环类化合物、其制备方法及其在医药上的应用 |
| CN117447402A (zh) * | 2023-10-18 | 2024-01-26 | 德明药泰生物技术（深圳）有限公司 | 芳香烃受体调节剂类化合物及其制备方法和应用 |
| CN117229208B (zh) * | 2023-11-13 | 2024-02-23 | 上海泽德曼医药科技有限公司 | 稠环类化合物、其制备方法及其在医药上的应用 |
| WO2026083733A1 (ja) * | 2024-10-18 | 2026-04-23 | 株式会社ヤクルト本社 | 試験方法、ゲル状組成物、及び試験装置 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992018123A2 (en) | 1991-04-10 | 1992-10-29 | Octamer, Inc. | A method for inhibition of retroviral replication |
| US5919970A (en) | 1997-04-24 | 1999-07-06 | Allergan Sales, Inc. | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
| ATE404539T1 (de) * | 1997-10-02 | 2008-08-15 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
| HRP20040102A2 (en) | 2001-07-09 | 2004-10-31 | Combinatorx | Combinations for the treatment of inflammatory disorders |
| WO2003053359A2 (en) * | 2001-12-19 | 2003-07-03 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| IL162533A0 (en) * | 2001-12-19 | 2005-11-20 | Atherogenics Inc | Chalcone derivatives and their use to treat diseases |
| JPWO2005063222A1 (ja) | 2003-12-26 | 2007-07-19 | 協和醗酵工業株式会社 | Ｈｓｐ９０ファミリー蛋白質阻害剤 |
| WO2006058201A2 (en) | 2004-11-23 | 2006-06-01 | Reddy Us Therapeutics, Inc. | Heterocyclic and bicyclic compounds, compositions and methods |
| GB0704718D0 (en) | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| EP2014651A1 (en) | 2007-07-12 | 2009-01-14 | Exonhit Therapeutics SA | Compounds and methods for modulating Rho GTPases |
| JP5439127B2 (ja) | 2009-11-13 | 2014-03-12 | 株式会社さいわいメディカル | 乾癬又はアトピー性皮膚炎治療剤 |
| WO2011156626A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| GB201216017D0 (en) * | 2012-09-07 | 2012-10-24 | Cancer Rec Tech Ltd | Inhibitor compounds |
| AU2013361314A1 (en) | 2012-12-20 | 2015-07-02 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
| GB201304041D0 (en) | 2013-03-06 | 2013-04-17 | Water Jel Europ Llp | Treatment and prophylaxis of radiation dermatitis |
| US10626094B2 (en) | 2014-10-14 | 2020-04-21 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof |
| JP7138654B2 (ja) * | 2017-03-29 | 2022-09-16 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 金属錯体 |
| US11548867B2 (en) * | 2017-07-19 | 2023-01-10 | Idea Ya Biosciences, Inc. | Amido compounds as AhR modulators |
| EP3752512B1 (de) * | 2018-02-13 | 2023-03-01 | Merck Patent GmbH | Metallkomplexe |
| TWI828664B (zh) | 2018-03-19 | 2024-01-11 | 愛爾蘭商Ｕｄｃ愛爾蘭責任有限公司 | 金屬錯合物 |
| JP2023533855A (ja) | 2020-07-16 | 2023-08-04 | ダーマヴァント サイエンシーズ ゲーエムベーハー | イソキノリン化合物およびそのＡｈＲ不均衡の治療への使用 |
| WO2023020512A1 (zh) * | 2021-08-16 | 2023-02-23 | 成都奥睿药业有限公司 | 取代的吡啶类似物、其制备方法及作为ahr调节剂的用途 |
| CN116947799B (zh) * | 2023-03-08 | 2024-05-03 | 上海泽德曼医药科技有限公司 | 酚类化合物、其制备方法及其在医药上的应用 |
-
2021
- 2021-05-27 JP JP2023502881A patent/JP2023533855A/ja active Pending
- 2021-05-27 KR KR1020237005000A patent/KR20230041021A/ko active Pending
- 2021-05-27 IL IL299756A patent/IL299756A/en unknown
- 2021-05-27 EP EP21842240.0A patent/EP4185566A4/en active Pending
- 2021-05-27 CA CA3185793A patent/CA3185793A1/en active Pending
- 2021-05-27 AU AU2021308209A patent/AU2021308209A1/en active Pending
- 2021-05-27 US US17/332,805 patent/US11267788B2/en active Active
- 2021-05-27 CN CN202180060054.5A patent/CN116157387A/zh active Pending
- 2021-05-27 WO PCT/US2021/034599 patent/WO2022015423A1/en not_active Ceased
- 2021-05-27 MX MX2023000263A patent/MX2023000263A/es unknown
-
2022
- 2022-01-28 US US17/587,812 patent/US11548853B2/en active Active
- 2022-10-28 US US18/050,888 patent/US11827605B2/en active Active
-
2023
- 2023-10-20 US US18/491,538 patent/US12252471B2/en active Active
-
2025
- 2025-02-14 US US19/053,643 patent/US20250282730A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533855A5 (https=) | ||
| JP7524172B2 (ja) | 新規な工程 | |
| AP1122A (en) | Therapeutically active compounds based on based on based on indazole bioisostere replacement of catechol in PDE4 inhibitors. | |
| JP2802547B2 (ja) | 抗炎症剤としてのイソキサゾリン化合物 | |
| TW199152B (https=) | ||
| JPH09500146A (ja) | 抗炎症剤としての３−アリール−２−イソオキサゾリン類 | |
| JP2024522990A5 (https=) | ||
| JPWO2008105515A1 (ja) | 新規なヒドロキサム酸誘導体 | |
| JP2000510865A (ja) | Ｔｎｆとｐｄｅ―ｉｖのインヒビターとしてのキノリンカルボキサミド | |
| JP2010503694A (ja) | インテグラーゼ阻害剤を調製するためのプロセスおよび中間体 | |
| UA65536C2 (en) | Substituted indazole derivatives, a pharmaceutical composition for the inhibition of phosphodiesterase type iv or the production of tumor necrosis factor, intermediate compounds | |
| TWI662019B (zh) | Fused tricyclic γ-amino acid derivative, preparation method and application thereof in medicine | |
| TW201138786A (en) | Therapeutic compounds | |
| TW200831510A (en) | Compounds | |
| JP2013521301A5 (https=) | ||
| JP2024544060A (ja) | Ａｐｏｌ１のスピロ環式阻害剤およびこれを使用する方法 | |
| AU2014258419A2 (en) | Dicarboxylic acid compound | |
| JP2002515433A (ja) | 抗ウイルス化合物 | |
| JP2023509944A5 (https=) | ||
| DE69520279T2 (de) | Bibphenylamid-derivate als 5-ht1d-antagonisten | |
| JPH11506772A (ja) | 抗ウイルス化合物 | |
| JP2005529084A (ja) | 結晶性パレコキシブナトリウム | |
| JP2017537957A (ja) | 置換されたピリジル−シクロアルキル−カルボン酸類、それらを含む組成物およびそれらの医学的使用 | |
| JP5826371B2 (ja) | ペメトレキセド塩の製造方法 | |
| JP2025502842A5 (https=) |